These results obtained with two independent progranulin depletions, by siRNA and neutralizing antibody, strongly indicate that progranulin depletion could be one of the new strategies for hematopoietic cancers. The gene discussed is GRN; the disease is hematopoietic and lymphoid cell neoplasm.